Your shopping cart is currently empty

SJ1008030 (compound 8) formic is a selective JAK2 degrader from the PROTAC class, exhibiting efficacy in inhibiting MHH-CALL-4 leukemia cell growth with an IC50 of 5.4 nM, and is potentially applicable for leukemia research [1].
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 5 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | SJ1008030 (compound 8) formic is a selective JAK2 degrader from the PROTAC class, exhibiting efficacy in inhibiting MHH-CALL-4 leukemia cell growth with an IC50 of 5.4 nM, and is potentially applicable for leukemia research [1]. |
| In vitro | SJ1008030 (compound 8) demonstrated activity in the CRLF2r cell line (MHH-CALL-4), with an IC50 of 5.4 nM after 72 hours (formic) [1]. SJ1008030 treatment at concentrations ranging from 0-4.3 μM for 72 hours (formic) led to dose-dependent degradation of JAK, GSPT1, and IKZF1 proteins in MHH-CALL-4 cells [1]. Additionally, at concentrations of 0-10 μM over 24 hours (formic), SJ1008030 induced dose-dependent degradation of JAK2 and GSPT1 proteins in xenografted bone marrow cells (SJBALL021415), indicating inhibition of the JAK-STAT signaling pathway [1]. |
| Molecular Weight | 919.96 |
| Formula | C43H45N13O9S |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.